IMWG consensus on risk stratification in multiple myeloma-Reference-Cited by-同舟云学术

IMWG consensus on risk stratification in multiple myeloma

Published:2013-08-26 Issue:2 Volume:28 Page:269-277
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Chng W J, ,Dispenzieri A,Chim C-S,Fonseca R,Goldschmidt H,Lentzsch S,Munshi N,Palumbo A,Miguel J S,Sonneveld P,Cavo M,Usmani S,Durie B GM,Avet-Loiseau H

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/leu2013247.pdf

Reference67 articles.

1. Rajkumar SV . Treatment of multiple myeloma. Nat Rev Clin Oncol 2011; 8: 479–491.

2. Kumar SK, Rajkumar SV, Dispenzieri A, Lacy MQ, Hayman SR, Buadi FK et al. Improved survival in multiple myeloma and the impact of novel therapies. Blood 2008; 111: 2516–2520.

3. Stewart AK, Richardson PG, San-Miguel JF . How I treat multiple myeloma in younger patients. Blood 2009; 114: 5436–5443.

4. Keats JJ, Fonseca R, Chesi M, Schop R, Baker A, Chng WJ et al. Promiscuous mutations activate the noncanonical NF-kappaB pathway in multiple myeloma. Cancer Cell 2007; 12: 131–144.

5. Zhu YX, Braggio E, Shi CX, Bruins LA, Schmidt JE, Van Wier S et al. Cereblon expression is required for the antimyeloma activity of lenalidomide and pomalidomide. Blood 2011; 118: 4771–4779.

Cited by 500 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multiple Myeloma and Retroperitoneal Fibrosis: A Rare Association Report and Literature Review;Transplantation Proceedings;2024-09

2. Biomarker-directed therapy in multiple myeloma;Current Opinion in Oncology;2024-08-23

3. Global characteristics and outcomes of autologous hematopoietic stem cell transplantation for newly diagnosed multiple myeloma: A study of the worldwide network for blood and marrow transplantation (WBMT);American Journal of Hematology;2024-08-19

4. AL amyloidosis manifesting as a vertebral amyloidoma secondary to an unrecognized plasmacytoma expressing cyclin D1 case report;International Journal of Surgery Case Reports;2024-08

5. Daratumumab in transplant-eligible patients with newly diagnosed multiple myeloma: final analysis of clinically relevant subgroups in GRIFFIN;Blood Cancer Journal;2024-07-08